Screening, degradation characteristics, and metabolic pathway of an efficient pyridine-degrading bacterial consortium MD1
CSTR:
Author:
Affiliation:

Clc Number:

Fund Project:

  • Article
  • |
  • Figures
  • |
  • Metrics
  • |
  • Reference
  • |
  • Related
  • |
  • Cited by
  • |
  • Materials
  • |
  • Comments
    Abstract:

    [Objective] To screen out the bacterial consortium capable of efficiently degrading pyridine and promote the degradation of high-concentration pyridine in wastewater. We screened out a pyridine-degrading bacterial consortium and studied the degradation characteristics and metabolic pathways of the consortium, aiming to provide a theoretical basis and technical support for the microbial degradation and complete mineralization of high-concentration pyridine in wastewater. [Methods] We used pyridine as the only nitrogen source to screen out an efficient pyridine-degrading bacterial consortium MD1 from the aerobic activated sludge and water samples of a pesticide wastewater treatment system. The 16S rRNA high-throughput sequencing was performed to reveal the bacterial species, diversity, and structure of MD1. Single-factor experiments were conducted to study the degradation characteristics of MD1. The metabolites of pyridine degradation by MD1 were initially identified by gas chromatography-mass spectrometry, and the possible degradation pathways of pyridine were deduced. [Results] The degradation rate of MD1 incubated at the optimal conditions of 30 ℃, pH 8.0, and 0.1% NaCl for 72 h reached 98.44%±0.27% when the initial concentration of pyridine was 1 400 mg/L. MD1 was mainly composed of Paracoccus, unclassified_Brucellaceae, and Achromobacter at the genus level. The results of metabolite detection suggested that the possible metabolic pathway of MD1 was pyridine→nicotinic acid→6-hydroxynicotinic acid→2,5-dihydroxypyridine→N-formylmaleamic acid→maleamic acid→maleic acid→CO2+H2O. [Conclusion] This study screened out a bacterial consortium MD1 with stable performance in degrading pyridine. The diversity, structure, and pyridine metabolic pathway of MD1 were analyzed, which enriched the resources of pyridine-degrading microorganisms.

    Reference
    Related
    Cited by
Get Citation

NIU Hongyu, GUO Jiayuan, CHEN Bozhi, CHEN Dandan, LONG Yu, YANG Haijun, PENG Rui. Screening, degradation characteristics, and metabolic pathway of an efficient pyridine-degrading bacterial consortium MD1. [J]. Acta Microbiologica Sinica, 2023, 63(11): 4330-4343

Copy
Share
Article Metrics
  • Abstract:
  • PDF:
  • HTML:
  • Cited by:
History
  • Received:March 30,2023
  • Revised:August 04,2023
  • Adopted:
  • Online: November 03,2023
  • Published: November 04,2023
Article QR Code